These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Clinical trials of IIb/IIIa receptor blockers in patients undergoing angioplasty. Mathew TP; Adgey AA Semin Interv Cardiol; 1999 Jun; 4(2):67-75. PubMed ID: 10473875 [TBL] [Abstract][Full Text] [Related]
44. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results. Popma JJ; Satler LF J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090 [TBL] [Abstract][Full Text] [Related]
45. Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. Braunwald E; Maseri A; Armstrong PW; Califf RM; Gibler WB; Hamm CW; Simoons ML; Van de Werf F Eur Heart J; 1998 Apr; 19 Suppl D():D22-30. PubMed ID: 9597519 [TBL] [Abstract][Full Text] [Related]
46. Future trials of antiplatelet agents in cardiac ischemia. Throckmorton DC N Engl J Med; 2001 Jun; 344(25):1937-9. PubMed ID: 11419432 [No Abstract] [Full Text] [Related]
47. Preferential benefit of platelet glycoprotein IIb/IIIa receptor blockade: specific considerations by device and disease state. Kereiakes DJ Am J Cardiol; 1998 Apr; 81(7A):49E-54E. PubMed ID: 9551595 [TBL] [Abstract][Full Text] [Related]
48. Spotlight on abciximab in patients with ischemic heart disease undergoing percutaneous coronary revascularization. Ibbotson T; McGavin JK; Goa KL Am J Cardiovasc Drugs; 2003; 3(5):381-6. PubMed ID: 14728074 [TBL] [Abstract][Full Text] [Related]
49. [Comparison of 2 platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization]. Rossi ML; Merlini PA Ital Heart J Suppl; 2001 Oct; 2(10):1130-2. PubMed ID: 11723620 [No Abstract] [Full Text] [Related]
50. Glycoprotein inhibitors and fibrinolysis in myocardial infarction. Ring BL JAMA; 2000 Dec; 284(24):3124-5. PubMed ID: 11135766 [No Abstract] [Full Text] [Related]
51. Massive pulmonary hemorrhage in a patient treated with a platelet glycoprotein IIb/IIIa inhibitor. Sitges M; Villa FP Int J Cardiol; 1997 Dec; 62(3):269-71. PubMed ID: 9476687 [TBL] [Abstract][Full Text] [Related]
52. Antiplatelet therapy for ischemic heart disease. Lange RA; Hillis LD N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308 [No Abstract] [Full Text] [Related]
53. Are stenting and glycoprotein IIb/IIIa blockade of good value in primary percutaneous coronary intervention? Cole JH; Weintraub WS Circulation; 2003 Dec; 108(23):2831-3. PubMed ID: 14662689 [No Abstract] [Full Text] [Related]
54. [Adjuvant therapy with a glycoprotein IIb-IIa inhibitor (abciximab) in coronary angioplasties with a high thrombotic risk]. Matos V; Marques AM; Oliveira H; Ramos D; Lopes P; Camacho M; Gonsalves A Rev Port Cardiol; 1998 Dec; 17(12):1001-5. PubMed ID: 9973861 [TBL] [Abstract][Full Text] [Related]
55. [Role of glycoprotein IIb/IIIa inhibitors in the treatment of degenerated aortocoronary saphenous vein grafts]. Brück M; Ludwig J; Flachskampf FA; Daniel WG Z Kardiol; 2002 Jan; 91(1):16-23. PubMed ID: 11963202 [TBL] [Abstract][Full Text] [Related]
56. Use of abciximab in interventional cardiology. Chronos N; Vahanian A; Betriu A; Emanuelsson H; Goldberg S; Gulba D; van Hout BA Eur Heart J; 1998 Apr; 19 Suppl D():D31-9. PubMed ID: 9597520 [TBL] [Abstract][Full Text] [Related]
58. Will blocking the platelet save the diabetic? King SB; Mahmud E Circulation; 1999 Dec 21-28; 100(25):2466-8. PubMed ID: 10604881 [No Abstract] [Full Text] [Related]
59. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L; N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425 [TBL] [Abstract][Full Text] [Related]
60. Effects on thrombin generation of the platelet glycoprotein IIb/IIIa inhibitors abciximab versus tirofiban during coronary intervention. Ambrose JA; Doss R; Geagea JM; Hawkey MC; Duvuri S; Giedd K; Dominguez A; Coppola J; Nguyen TH; Palla V; Barua RS; Saha DC Am J Cardiol; 2001 May; 87(10):1231-3: A8. PubMed ID: 11356410 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]